PharmaBoardroom

China Pharma News Roundup June 1st 2020

A roundup of some of the top stories in China’s healthcare and life sciences industry, including challenges for Chinese biotechs in the…

COVID-19 Vaccines: AstraZeneca, GSK, J&J & Pfizer…

During the 28 May 2020 IFPMA media briefing on COVID-19 vaccines, four of the pharmaceutical industry’s leading executives discussed where their…

Top MSD & Sandoz Execs on the Reality of COVID-19 R&D…

During the 30 April IFPMA virtual media briefing on COVID-19 treatments, key global executives pushed beyond catchy headlines to discuss the current…

Indian Pharma Manufacturing: Back in Business

COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and active pharmaceutical ingredients for…

Gerard Anderson – Professor, Johns Hopkins University…

Dr Gerard Anderson of Johns Hopkins University Bloomberg School of Public Health critiques the US response to the COVID-19 pandemic, before explaining…

COVID-19 Vaccine: Sanofi CEO Paul Hudson Commits to “Bring…

In a recent interview with Financial Times, Sanofi CEO Paul Hudson set out to clarify some recent comments that the US would get priority access to a…

Sanofi CEO Paul Hudson on GSK Vaccine Collaboration

In an interview with Financial Times correspondent Leila Abboud at the FT Global Boardroom video conference on the 14th of May, Paul Hudson, CEO of…

Pharma Faces: Jorge Alderete, ALK Americas

Jorge Alderete, president of ALK Americas, recently spoke to PharmaBoardroom about his 20+ years with the Danish mid-cap, the challenges in…

What Can Brazil’s Pharma Industry Learn from India?

The editorial team at Panorama Farmaceutico explain why coordinated action is needed within Brazilian pharma to reduce dependence on API imports from…